Clinical Trial Update: Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating recombinant human adenovirus type 5 combined with HAIC of FOLFOX for intrahepatic cholangiocarcinoma is ongoing, with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• HAIC of FOLFOX
• Recombinant human adenovirus type 5 (Adenovirus type 5 vector)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Cholangiocarcinoma, Intrahepatic | Phase 4 | Status: UNKNOWN